SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY: Long-Lasting Disease Remission With Third Line Therapy With Gilteritinib. Mediterr J Hematol Infect Dis 2024, 16 (1), e2024079. https://doi.org/10.4084/MJHID.2024.079.